Protect with confidence1 your patient's healthy parathyroid tissue — and their quality of life2
PTeye™ parathyroid detection system
The PTeye™ parathyroid detection system is an intra-operative probe-based technology to aid you in confirming suspected parathyroid tissue during thyroid and parathyroid surgery.3
Up to 22% of thyroid surgeries result in incidental parathyroid removal.4 This puts patients at risk for hypoparathyroidism — a condition associated with a number of short- and long-term complications.2,5-9
up to
96%
accuracy3
Real-time confirmation
Add to your visual identification of the parathyroid gland with PTeye™ parathyroid detection system, providing real-time confirmation with up to 96% accuracy.3
PTeye™ parathyroid system is based on an intraoperative technique that uses near-infared (NIR) autoflourescence for in vivo, real-time confirmation of visually suspected parathyroid tissue.3
Identify with confidence
88.9%
Confirming parathyroid gland tissue in 88.9% (24/27) of the cases1
When identified with medium confidence, PTeye™ was highly beneficial for further improving the surgeon's confidence and confirming PG tissue in 88.9% (24/27) of cases¹
7.4%
Prevented surgeon error in
7.4% (2/27) of times1
When identified with medium confidence, PTeye™ was highly beneficial for further improving the surgeon's confidence and preventing surgeon error in 7.4% (2/27).¹
Surgeons reported improved confidence in identifying parathyroid glands by using PTeye™1
In a study, surgeons reported that using the PTeye™ system improved confidence in identifying the parathyroid gland, regardless of the experience.¹
Carmen C. Solórzano, M.D., FACS
1
Kiernan CM, Thomas G, Baregamian N, Solόrzano CC. Initial clinical experiences using the intraoperative probe-based parathyroid autofluorescence identification system - PTeye™ during thyroid and parathyroid procedures. J Surg Oncol. 2021;124:271–281.
2
Siggelkow, H, Clarke, BL, Germak, J, et al. Burden of illness in not adequately controlled chronic hypoparathyroidism: Findings from a 13-country patient and caregiver survey. Clin Endocrinol (Oxy), 2020; 92: 159–168. doi: 10.1111/cen.14128. Epub 2019 Dec 11. PMID: 31721256; PMCID: PMC7027891.
3
PTeye IFU M012700C001
4
Applewhite M. et al Incidence, Risk Factors, and Clinical Outcomes of Incidental Parathyroidectomy During Thyroid Surgery, Ann Surg Oncol 2016 Dec; 23(13):4310–4315. doi: 10.1245/s10434-016-5439-1. Epub 2016 Aug 19. PMID: 27541813.
5
Büttner M, Singer S, Taylor K. Quality of life in patients with hypoparathyroidism receiving standard treatment: an updated systematic review. Endocrine. 2024 Apr 5. doi: 10.1007/s12020-024-03807-2. Epub ahead of print. PMID: 38578400.
6
Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L. Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study. J Bone Miner Res. 2013 Nov;28(11):2277–85. doi: 10.1002/jbmr.1979. PMID: 23661265.
7
Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L. Postsurgical hypoparathyroidism--risk of fractures, psychiatric diseases, cancer, cataract, and infections. J Bone Miner Res. 2014 Nov;29(11):2504–10. doi: 10.1002/jbmr.2273. PMID: 24806578
8
Underbjerg L, Sikjaer T, Rejnmark L. Long-Term Complications in Patients With Hypoparathyroidism Evaluated by Biochemical Findings: A Case-Control Study. J Bone Miner Res. 2018 May;33(5):822–831. doi: 10.1002/jbmr.3368. Epub 2018 Feb 14. PMID: 29281760.
9
Gosmanova EO, Chen K, Ketteler M, et al. Risk of Cardiovascular Conditions in Patients with Chronic Hypoparathyroidism: A Retrospective Cohort Study. Adv Ther. 2021 Aug;38(8):4246–4257. doi: 10.1007/s12325-021-01787-7. Epub 2021 Jun 24. PMID: 34165700; PMCID: PMC8342323.